It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pleomorphic adenoma gene 1 (PLAG1) is a transcription factor involved in cancer and growth. We discovered a de novo DNA motif containing a PLAG1 binding site in the promoters of genes activated during zygotic genome activation (ZGA) in human embryos. This motif was located within an Alu element in a region that was conserved in the murine B1 element. We show that maternally provided Plag1 is needed for timely mouse preimplantation embryo development. Heterozygous mouse embryos lacking maternal Plag1 showed disrupted regulation of 1,089 genes, spent significantly longer time in the 2-cell stage, and started expressing Plag1 ectopically from the paternal allele. The de novo PLAG1 motif was enriched in the promoters of the genes whose activation was delayed in the absence of Plag1. Further, these mouse genes showed a significant overlap with genes upregulated during human ZGA that also contain the motif. By gene ontology, the mouse and human ZGA genes with de novo PLAG1 motifs were involved in ribosome biogenesis and protein synthesis. Collectively, our data suggest that PLAG1 affects embryo development in mice and humans through a conserved DNA motif within Alu/B1 elements located in the promoters of a subset of ZGA genes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
2 Karolinska Institutet, Bioinformatics and Expression Analysis core facility, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
3 Competence Centre on Health Technologies, Tartu, Estonia (GRID:grid.487355.8); University of Helsinki and Folkhälsan Institute of Genetics, Molecular Neurology Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
4 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Helsinki and Folkhälsan Institute of Genetics, Molecular Neurology Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
5 Intervention and Technology, Karolinska Institutet, Department of Clinical Science, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
6 La Trobe University, Department of Physiology, Anatomy and Microbiology, Victoria, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938)
7 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Helsinki, and Folkhälsan Institute of Genetics, Research Programs Unit, Molecular Neurology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); King’s College London, Guy’s Hospital, School of Basic and Medical Biosciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
8 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Intervention and Technology, Karolinska Institutet, Department of Clinical Science, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)